Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Author: Lisa Levin | January 04, 2023 02:17pm

Gainers

  • Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.
  • Crown ElectroKinetics Corp. (NASDAQ:CRKN) climbed 162% to $0.4909 after the company announced it acquired Amerigen 7.
  • Cryptyde, Inc. (NASDAQ:TYDE) gained 108% to $0.4022.
  • Geron Corporation (NASDAQ:GERN) shares jumped 53.3% to $3.6800 after the company announced top-line results from the IMerge Phase 3 trial of imetelstat in lower risk MDS. The trial met the primary 8-week transfusion independence (TI) endpoint and key secondary 24-week TI endpoint.
  • Shift Technologies, Inc. (NASDAQ:SFT) rose 49% to $0.2350.
  • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) jumped 42.4% to $0.4132. The company earlier reported in 13G filing Sabby Volatility Warrant Master Fund held 11% stake in Neptune Wellness Solutions.
  • Reunion Neuroscience Inc. (NASDAQ:REUN) gained 27.8% to $1.33.
  • Armata Pharmaceuticals, Inc. (NASDAQ:ARMP) surged 25% to $ 1.3799.
  • AIM ImmunoTech Inc. (NYSE:AIM) jumped 23.3% to $ 0.3997.
  • NuZee, Inc. (NASDAQ:NUZE) gained 21.8% to $12.85. NuZee adopted a 1-for-35 reverse stock split.
  • Atlis Motor Vehicles, Inc. (NASDAQ:AMV) shares climbed 21.4% to $3.69.
  • ZK International Group Co., Ltd. (NASDAQ:ZKIN) jumped 20% to $0.50.
  • Elys Game Technology, Corp. (NASDAQ:ELYS) shares gained 20% to $0.3089 after dropping 8% on Tuesday. Elys Game Technology and Cloakbook were recently granted a license to commence sportsbook operations in Washington, D.C.
  • Lizhi Inc. (NASDAQ:LIZI) rose 19.6% to $0.67 after declining around 3% on Tuesday.
  • Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) jumped 19.5% to $ 0.8498. Galmed reported results from the open-label part of the ARMOR study.
  • ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) surged 18.4% to $0.5150. ASLAN Pharmaceuticals and Thermo Fisher Scientific reported a partnership to manufacture high concentration formulation of eblasakimab for future studies.
  • Dada Nexus Limited (NASDAQ:DADA) gained 18.4% to $10.45. Shares of Chinese companies traded higher after Chinese regulators reportedly approved a capital raise for Ant Group.
  • Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) gained 16.4% to $3.05. Eloxx Pharmaceuticals, last month, announced a 1-for-40 reverse stock split.
  • Oblong, Inc. (NASDAQ:OBLG) shares rose 15.6% to $2.02 after the company reported a 1-for-15 reverse stock split.
  • Baozun Inc. (NASDAQ:BZUN) gained 15.3% to $6.50.
  • Eliem Therapeutics, Inc. (NASDAQ:ELYM) gained 15.1% to $3.81.
  • I-Mab (NASDAQ:IMAB) rose 15% to $4.88.
  • Genprex, Inc. (NASDAQ:GNPX) gained 14.2% to $1.8150.
  • GDS Holdings Limited (NYSE:GDS) jumped 13.8% to $27.00. Shares of Chinese companies traded higher after Chinese regulators reportedly approved a capital raise for Ant Group.
  • Kingsoft Cloud Holdings Limited (NASDAQ:KC) rose 13.2% to $4.46. Kingsoft Cloud Holdings recently successfully listed on Hong Kong Stock Exchange. Shares of Chinese companies traded higher after Chinese regulators reportedly approved a capital raise for Ant Group.
  • Poseida Therapeutics, Inc. (NASDAQ:PSTX) gained 13% to $6.54. HC Wainwright & Co. initiated coverage on Poseida Therapeutics with a Buy rating and announced a price target of $15.
  • Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) gained 12.3% to $17.90. Deciphera Pharmaceuticals announced an exploratory analysis of data from the INTRIGUE Phase 3 study of Qinlock using circulating tumor DNA (ctDNA).
  • InMed Pharmaceuticals Inc. (NASDAQ:INM) rose 8.7% to $2.40 after gaining over 9% on Tuesday.


Losers

  • Vera Therapeutics, Inc. (NASDAQ:VERA) shares tumbled 64.5% to $6.51 after the company announced topline results of the Phase 2b ORIGIN clinical trial of atacicept for the treatment of IgA nephropathy.
  • Enovix Corporation (NASDAQ:ENVX) dropped 43% to $6.80 following a livestream presentation from company management regarding an update on production, commercialization and recent management additions.
  • ReShape Lifesciences Inc. (NASDAQ:RSLS) fell 33.8% to $10.35 after climbing 132% on Tuesday. Reshape Lifesciences recently announced a 1-for-50 reverse stock split.
  • Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) fell 32.8% to $6.80. The FDA notified Phathom Pharmaceuticals that no action would be taken on the company's new drug application (NDA) for vonoprazan, under review as a treatment for erosive esophagitis, on or before the current Prescription Drug User Fee Act (PDUFA) target action date of January 11, 2023.
  • Moolec Science SA (NASDAQ:MLEC) dropped 31.8% to $6.21.
  • 180 Life Sciences Corp. (NASDAQ:ATNF) dropped 29% to $3.76. 180 Life Sciences announced publication of a review on the biological basis of Dupuytren's disease in the Journal Trends in Molecular Medicine.
  • Lucira Health, Inc. (NASDAQ:LHDX) fell 24.5% to $0.4525. Lucira Health shares jumped 440% on Tuesday after the company announced it submitted an Emergency Use Authorization application to the FDA for OTC use of its COVID-19 & Flu test.
  • Innovid Corp. (NYSE:CTV) dropped 23.8% to $1.37.
  • Jasper Therapeutics, Inc. (NASDAQ:JSPR) fell 22.2% to $2.13. Jasper Therapeutics shares jumped 476% on Tuesday after the company announced data from the first three participants in a Phase 1/2 clinical trial evaluating the addition of briquilimab (JSP191) to an existing bone marrow transplantation regimen in individuals with sickle cell disease (SCD) and beta-thalassemia.
  • Kidpik Corp. (NASDAQ:PIK) fell 17.8% to $0.7151.
  • Gelesis Holdings, Inc. (NYSE:GLS) dropped 17.3% to $0.43.
  • Airspan Networks Holdings Inc. (NYSE:MIMO) fell 15% to $1.13.
  • Seer, Inc. (NASDAQ:SEER) dropped 14.2% to $5.02 after B of A Securities downgraded the stock from Neutral to Underperform and lowered its price target from $9 to $6.50.
  • Swvl Holdings Corp. (NASDAQ:SWVL) fell 13.3% to $0.1631. Swvl recently announced the commencement of a strategic review process.
  • Timber Pharmaceuticals, Inc. (NYSE:TMBR) dropped 12.9% to $2.0550.
  • Chemomab Therapeutics Ltd. (NASDAQ:CMMB) fell 11.6% to $2.60. Chemomab Therapeutics recently reported topline results from its Phase 2a trial assessing CM-101 in non-alcoholic steatohepatitis (NASH) patients.
  • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) dropped 9.1% to $10.93.
  • VEON Ltd. (NASDAQ:VEON) declined 7.7% to $0.48.
  • MiNK Therapeutics, Inc. (NASDAQ:INKT) fell 7.3% to $2.30.

Also Check This Out $1.2 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying

Posted In: AIM AMV ARMP ASLN ATNF BZUN CMMB CRKN CTV DADA DCPH DFLI ELOX ELYM ELYS ENVX GDS GERN GLMD GLS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist